* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Non-hepatotropic Viruses
Influenza A virus wikipedia , lookup
Dirofilaria immitis wikipedia , lookup
Herpes simplex wikipedia , lookup
Cryptosporidiosis wikipedia , lookup
Onchocerciasis wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Sarcocystis wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Ebola virus disease wikipedia , lookup
Trichinosis wikipedia , lookup
Chagas disease wikipedia , lookup
Herpes simplex virus wikipedia , lookup
West Nile fever wikipedia , lookup
Neonatal infection wikipedia , lookup
Foodborne illness wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Marburg virus disease wikipedia , lookup
Antiviral drug wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Oesophagostomum wikipedia , lookup
Schistosomiasis wikipedia , lookup
Leptospirosis wikipedia , lookup
Henipavirus wikipedia , lookup
Lymphocytic choriomeningitis wikipedia , lookup
Milad Haddad, MD Head of Gastroenterology Department, Ibn Alnafis Hospital Liver Functions • Metabolic • Synthetic & storage • Excretory & detoxification • Immune & Filtering Metabolic Synthetic & Storage Excretory & Detoxification Immune & Filtering Glucose, protein & fat Hormones & vitamins Proteins (clotting factors & acute phase proteins) Hormones & vitamins Store: glycogen, fat, vitamins, iron, & copper Bilirubin, bile acids, cholesterol, & phospholipids Detoxification of drugs & toxins Poisons, nutrients, & damaged cells Excretion of IgA Kupffer cells (macrophages) Hepatitis Viruses A Hepatotropic Viruses A-E hepatitis viruses: HAV, HBV, HCV, HDV, & HEV Non-A-E hepatitis viruses: • Flaviviridae: GBV-C/HGV, Yellow fever virus (YFV) • Circoviridae: Torque teno virus (TTV), Sanban, Yonban, SEN viruses, TTV-like mini virus (TTMV), TTV-like midi virus (TTMDV) B Non-hepatotropic Viruses • Herpesviridae : EBV, CMV, HSV, VZV, & HHV – 6 • Severe acute respiratory syndrome/ coronavirus (SARS/CoV) • Parvovirus B19 • Measles virus • HIV • Lassa, Marburg, Ebola Hepatitis Viruses Natural History of HBV infection HCC 5-10% Acute infection Chronic infection 90% of children < 5% of adults Cirrhosis 30% Liver Transplantation 23%/5 yr Decompensation Torreti J. Gastroneterology, 2000;118:S83-103 Fattovich G.Hepatology, 1995;21;77-92. Moyer LA. AmJ Prov Med. 1994:10:45-55 Death Natural History of HCV infection HCC Cirrhosis Chronic hepatitis HCV infection 1%/yr (1-3%/yr) 15% (10-30%) 25 years 80% (60-95%) 100% Predicted outcome of HAV infection Parameter Predicted Outcome Children (<5 years) Adults Inapparent disease 80-95% 10-25% Anicteric or icteric disease 5-20% 75-90% Complete recovery 99+% 98+% Chronic disease Mortality rate • ≤ 14 years • 15-39 years • ≥ 40 years None • 0.1% • 0.3% • 2.1% Hollinger FB and Ticehurst JR. Hepatitis A virus. In: Fields Virology, 3rd ed. Philadelphia, Lippincott - Raven, 1996:735-782 Epidemiology From 11% to 22% of patients with acute hepatitis A require hospitalization. An average length of stay of 4.6 days, costing on average $7926 per patient. On average, 27 workdays are lost per adult case of hepatitis A. • Hepatitis A is the most common form of acute viral hepatitis worldwide. It is a self-limited infection Worldwide Endemicity of HAV Infection HAV ENDEMICITY Very high High Intermediate Low Very low REGIONS BY EPIDEMIOLOGICAL PATTERN Africa, parts of South America, the Middle East and of south-east Asia AVERAGE AGE OF PATIENTS (YEARS) Under 5 MOST LIKELY MODE OF TRANSMISSION • • Person-to-person Contaminated food and water Brazil’s Amazon basin, China and Latin America 5-14 • • Person-to-person Outbreaks/contamin ated food or water Southern and Eastern Europe, some regions of the Middle East 5-24 • • Person-to-person Outbreaks/contamin ated food or water Australia, USA, Western Europe 5-40 • Common source outbreaks • Exposure during travel to high endemicity areas, uncommon Source Northern Europe and Japan Over 20 Virology of HAV • Nonenveloped Icosahedral spherical shape. • 27-32 nm in diameter. • HAV genome consists of a positive single-stranded RNA that is 7.48 kb long and linear. • HAV has only 1 known serotype in humans and no antigenic crossreactivity with HBV, HCV, HDV, HEV, or GBV-C. • No cytopathic effect is observed. • HAV infection provides a lifelong protection. HAV Genomic Organization Millward-Sadler GH, Wright R, Arther MJP, editors. Wright’s liver and biliary disease. 3rd ed.London: WB Saunders; 1992. p 679 Modes of Transmisiion Modes of Transmission HAV Stability HAV is extremely resistant to degradation by environmental conditions HAV is resistant to: • • • Thermal denaturation (survives at 70°C for up to 10 min) Acid treatment (pH 1 for 2 h at room temperature), 20% ether, chloroform, dichlorodifluoromethane, and trichlorotrifluoroethane Perchloracetic acid (300 mg/l for 15 min at 20°C) Detergent inactivation (survives at 37°C for 30 min in 1% SDS) Storage at –20°C for years HAV is capable of surviving in sea water (4%survival rate), dried feces at room temperature for 4 weeks live oysters for 5 days WHO/CDS/CSR/EDC/2000.7: hepatitis A HAV is inactivated by: Heating to 85°C for 1 min Autoclaving (121°C for 20 min) Ultraviolet radiation (1.1 W at a depth of 0.9 cm for 1 min) Formalin (8% for 1 min at 25°C) â-propriolactone (0.03% for 72 h at 4°C) Potassium permanganate (30 mg/l for 5 min) Iodine (3 mg/l for 5 min) Chlorine (free residual chlorine concentration of 2.0 to 2.5 mg/l for 15 min) Chlorine-containing compounds (3 to 10 mg/l sodium hypochlorite at 20°C for 5 to 15 min) Shellfish from contaminated areas should be heated to 90°C for 4 min or steamed for 90 sec Pathogenesis • • • • • • • • After HAV is ingested and survives gastric acid, it traverses the small intestinal mucosa, reaches the liver via the portal vein, and is taken up by hepatocytes. In hepatocytes, virus particles replicate, assemble, and are secreted into the biliary canaliculus, from which they pass into the bile duct and back to the small intestine, with eventual excretion in the feces. The enterohepatic cycles of the virus life cycle continue until neutralizing antibodies and other immune mechanisms interrupt the cycle. The lack of injury to cells in cell culture systems suggests that HAV is not cytopathic. Immunologically mediated cell damage is more likely. The emergence of anti-HAV could result in hepatic necrosis during immunologically mediated elimination of HAV. Death appears to be inevitable when necrosis involves more than 65 - 80% of the total hepatocyte fraction. In patients who survive an episode of acute fulminant hepatic failure, neither functional nor pathologic sequelae are common, despite the widespread necrosis. The damaged hepatic tissue is usually restored within 8 to 12 weeks. Detection of HAV and Infectivity of Human Secretions or Excretions Secretion/Excretion Comment Stool The main source of infection. HAV is detectable during the incubation period and for several weeks after the onset of disease. After the onset of symptoms, HAV is detectable in 45% and 11% of fecal specimens collected during the first and second weeks of illness, respectively, whereas HAV RNA (by PCR assay) is detectable for 4 to 5 months. Blood Viremia is present during the incubation period. Blood collected 3 and 11 days before the onset of symptoms has caused post-transfusion infection in recipients. Chronic viremia does not occur. Bile HAV has been detected in the bile of chimpanzees infected with HAV. Urine HAV is detected in low titer during the viremic phase. A urine sample was reported to be infectious after oral inoculation. Urine contaminated with blood was also infectious. Nasopharyngeal Unknown in humans. HAV has been identified in the oropharynx of experimentally infected chimpanzees. Semen, vaginal fluid Uncertain. HAV may be detectable during the viremic phase. Person-to-person contact - Households - Sexual contact: men who have sex with men - Child day care centers Food & water contamination - Infected food handlers - Raw shellfish Blood & blood products exposure (rare) - Transfusion - IV drug abusers Modes of Transmission Transmission route Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Food-Borne • Ø Ø Ø • Fecal-Oral • Ø Ø Ø • Water-Borne • Ø Ø Ø • Raw-Shellfish • Ø Ø Ø Suspected IntraInstitutional • • • • • IV drug use ∆ • • • Ø Transfusion ∆ • • • ∆ Hemodialysis ∆ • • • Ø Sexual ∆ • ∆ • ∆ Oral-Oral • ∆ Ø Ø • Household • ∆ ∆ ∆ • Perinatal ∆ • ∆ • ∆ • Common ∆ Infrequent Ø Never Role of non-human primates in the transmission of HAV Various monkey species such as chimpanzees, owl, cynomolgus, rhesus, stump-tailed, & African green monkeys, tamarins, marmosets and squirrel monkeys are susceptible to HAV. HAV-induced disease in non-human primates resembles human disease, but is usually milder, or subclinical, followed by complete recovery. Simian HAV strains, closely related antigenically to human HAV strains despite major divergence at the nucleotide level (>10%). Well documented is the natural transmission of human HAV from experimentally infected animals to humans. High Risk Groups for HAV Infection People in household/sexual contact with infected persons Medical and paramedical personnel in hospitals International travellers from developed countries to regions of the world where HAV is endemic (3/1000 to 20/1000 people per month’s stay abroad) Persons living in regions with endemic hepatitis A Persons residing in areas where extended community outbreaks exist Preschool children attending daycare centres, their parents and siblings Day-care centre employees Residents and staff of closed communities (institutions) Refugees residing in temporary camps following catastrophes Homosexually active men Injecting drug users using unsterilized injection needles Persons with clotting factor disorders Persons with chronic liver disease Food-service establishments/food handlers Persons working with non-human primates Reported risk factors among persons with hepatitis A United States, 1990–2000 CHARACTERISTICS OF FOODBORNE TRANSMISSION Transmission due to contamination of food at the point of sale or service The source of most reported foodborne hepatitis A outbreaks has been HAV-infected food handlers present at the point of sale (such as in a restaurant) or who prepare food for social events (such as a wedding). A single HAV-infected food handler can transmit HAV to dozens or even hundreds of persons and cause a substantial economic burden to public health [18, 19]. The societal cost of a single foodborne outbreak of hepatitis A in Denver involving 43 cases was estimated to be more than $800,000, with 190% of these costs borne by the public health department and attributed to immunoglobulin administration [18]. CHARACTERISTICS OF FOODBORNE TRANSMISSION Transmission due to contamination of food during growing, harvesting, processing, or distribution Hepatitis A outbreaks have been also associated with consumption of fresh produce contaminated with HAV during cultivation, harvesting, processing, or distribution Outbreaks involving a food item that was contaminated before distribution are particularly challenging to identify and might be widely distributed geographically. Transmission due to exposure to contaminated water. • Water treatment processes and dilution within municipal water systems are apparently sufficient to render HAV noninfectious, although no studies have demonstrated which specific treatment processes are the most effective. • Outbreaks of hepatitis A among persons who use small private or community wells or swimming pools have been reported, and contamination by adjacent septic systems has been implicated as the source of contamination [49–53]. • hepatitis A outbreaks after flooding-related sewage contamination of potable water sources is recognized. Guidelines for Epidemic Measures Determination of mode of transmission, whether personto-person or by common vector (vehicle). Identification of the population exposed to increased risk of infection. Elimination of common sources of infection. Improvement of sanitary and hygienic practices to eliminate faecal contamination of food and water. Hepatitis A vaccination has been shown to be effective in controlling outbreaks of infection in communities that have high or intermediate rates of infection, provided a sufficient percent of the target population is reached. Passive immunization provides temporary protection, but it is not effective in controlling HAV on a community level. WHO/CDS/CSR/EDC/2000.7 Thank You